TDR summary Report 2004
Covering years 2003-2004
This brief Summary Report covers the output of the 2002-2003 biennium. In this report, TDR has selected a few of its key partnership achievements of the 2002-2003 biennium to give the reader an impression of the scope of TDR's research and capability strengthening activities and their impact.
Many of these highlights have resulted from research that has been in the TDR pipeline for several years, emphasizing the need for TDR to develop and maintain a strong portfolio of research activities across the full spectrum of research endeavour, from innovative laboratory driven research, through product R&D, into the area of implementation research. We also present a few high impact projects from our current portfolio. This provides a perspective on potential achievements to which TDR will significantly contribute, with our partners, by the end of 2005.
The 2002-2003 highlights and the high impact products anticipated by the end of 2005 range from upstream basic research on African sleeping sickness, where new drugs and diagnostics are desperately needed, through drug development successes for leishmaniasis, to downstream implementation research in the case of malaria and river blindness, where new methods of home management and community based treatments can usefully complement and support resource constrained health systems.
Indicators Account Report 2004